ABEL GONZALEZ: Open Payments
NPI 1962445940 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,165 in 236 payments from 23 companies in 2025. Trend: 2023 $13,787 · 2024 $32,341 · 2025 $18,165
Honoraria: $9,975Food & beverage: $5,635Travel & lodging: $2,454Education: $100
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $9,006 |
| Supernus Pharmaceuticals, Inc. | 18 | $4,668 |
| Alkermes, Inc. | 20 | $589 |
| E.R. Squibb & Sons, L.L.C. | 15 | $495 |
| Vanda Pharmaceuticals Inc. | 19 | $467 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $466 |
| Otsuka America Pharmaceutical, Inc. | 17 | $410 |
| Collegium Pharmaceutical, Inc. | 19 | $285 |
| Neurocrine BioSciences, Inc. | 6 | $281 |
| ABBVIE INC. | 18 | $217 |
Products named: Auvelity, Qelbree, REXULTI, COBENFY, FANAPT, CAPLYTA, ARISTADA, Jornay PM.
Industry payments across PA — which companies pay providers there.
